CIO Applications recently sat down with our founder and CEO Michael Grunkin. The technology print magazine focuses on usage of various tech start ups. In the latest issue the spotlight was placed on the marketplace of machine learning...

FOR IMMEDIATE RELEASE  — April 30, 2019 Visiopharm is delighted to announce Adrian Arechiga Ph.D. as its new Chief Marketing Officer. Highly experienced as a Senior Marketing Director, Adrian has an impressive track record of working...

Digital pathology is undergoing a revolutionary change with the introduction of state-of-the-art pattern recognition via/with deep learning. The transition from feature engineering and classical machine learning to end-to-end deep learning have...

Digital Pathology is undergoing a revolutionary change with the introduction of state-of-the-art pattern recognition via/with deep learning. The transition from feature engineering and classical machine learning to end-to-end deep learning has...

ATP, the Danish Growth Fund and the C. L. David Foundation and Collection are among the new investors.  The increased capital commitment is an essential part of the company’s growth strategy within the field of tissue diagnostics and...